Green Thumb Industries (GTBIF) Intangibles (2019 - 2026)
Green Thumb Industries' (GTBIF) quarterly Intangibles came in at $424.1 million in Q1 2026, down 10.85% YoY from $475.7 million in Q1 2025, and down 2.88% on a QoQ basis from $436.7 million in Q4 2025.
Green Thumb Industries (GTBIF) Intangibles (2019 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 8 years of Intangibles data on file, last reported at $424.1 million in Q1 2026.
- Quarterly Intangibles fell 10.85% year-over-year to $424.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $424.1 million (down 10.85% YoY) and the FY2025 annual result came in at $436.7 million, down 10.57% from the prior year.
- Intangibles declined to $424.1 million in Q1 2026, from $436.7 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $674.7 million in Q1 2022 to a low of $424.1 million in Q1 2026.
- A 5-year average of $533.3 million and a median of $526.0 million in 2024 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2022 — Intangibles jumped 70.37% — and 2023, when it dropped 14.49%.
- Tracing GTBIF's Intangibles over 5 years: stood at $589.5 million in 2022, then slipped by 8.62% to $538.7 million in 2023, then dropped by 9.35% to $488.3 million in 2024, then slipped by 10.57% to $436.7 million in 2025, then retreated by 2.88% to $424.1 million in 2026.
- The last three Intangibles figures came in at $424.1 million (Q1 2026), $436.7 million (Q4 2025), and $442.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.12 Bn |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn | 435.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 435.59 Mn |
| Mar 31, 2026 | 424.11 Mn |
| Dec 31, 2025 | 436.68 Mn |
| Sep 30, 2025 | 442.73 Mn |
| Jun 30, 2025 | 462.41 Mn |
| Mar 31, 2025 | 475.71 Mn |
| Dec 31, 2024 | 488.29 Mn |
| Sep 30, 2024 | 500.86 Mn |
| Jun 30, 2024 | 513.43 Mn |
| Mar 31, 2024 | 526.01 Mn |
| Dec 31, 2023 | 538.68 Mn |
| Sep 30, 2023 | 551.42 Mn |
| Jun 30, 2023 | 564.17 Mn |
| Mar 31, 2023 | 576.91 Mn |
| Dec 31, 2022 | 589.52 Mn |
| Sep 30, 2022 | 640.99 Mn |
| Jun 30, 2022 | 659.60 Mn |
| Mar 31, 2022 | 674.69 Mn |
| Dec 31, 2021 | 675.49 Mn |
| Sep 30, 2021 | 549.18 Mn |